Thus, there is an urgent need to develop advanced treatment strategies, such as combining traditional immunotherapies—like immune checkpoint inhibitors—with other anti-cancer treatments, including targeted therapies (e.g., TGF-β or PI3K/AKT/mTOR inhibitors) and chemotherapy. The gene discussed is MTOR; the disease is cancer.